Results 171 to 180 of about 778,738 (261)

Quantifying brain-age gap in people with HIV on antiretroviral therapy using plasma neurofilament light chain. [PDF]

AIDS
Park H, Hyle EP, Tassiopoulos KK, Gisslén M, Rubin LH, Mukerji SS, Parker RA.   +6 more
europepmc   +1 more source

EMBODIED DATA/SUBALTERN DATAFICATION: Reimagining the Data‐Based City Through Quantified Lived Experience

International Journal of Urban and Regional Research, EarlyView.
Abstract This article outlines possibilities for counter configurations of data‐based urbanisms, whereby data practices, rather than reproducing logics of urban entrepreneurialism and smart‐city governance, are made from within urban peripheral territories.
Andrés Luque‐Ayala, Rodrigo Firmino
wiley   +1 more source

Toronto's drug policy paradox: Harm reduction sites and drug police occurrences in Toronto neighborhoods (1992–2020)

Criminology, EarlyView.
Abstract Discourse around drug policy presents a stark contrast between policing and harm reduction models, sparking debates on the state's regulatory versus protective role. Canada is an ideal case to study drug policy models due to its global recognition as a leader in harm reduction alongside continued reliance on policing of drugs.
Taylor Domingos
wiley   +1 more source

Prevalence and risk factors of cognitive frailty in people with HIV. [PDF]

AIDS
Milic J, Calza S, Lazzarini L, Cocchi M, Motta F, Renzetti S, Sighinolfi L, Belli M, Todisco V, Albertini M, Gallerani A, Menozzi M, Cuomo G, Mancini G, Mussi C, Mussini C, Calcagno A, Guaraldi G.   +17 more
europepmc   +1 more source

Trajectories of medication for opioid use disorder and their impact on HIV testing among people who inject drugs in India: A longitudinal assessment of clinic‐based data

Addiction, Volume 120, Issue 4, Page 745-755, April 2025.
Abstract Aims The aim of this study was to identify longitudinal trajectories of medication for opioid use disorder (MOUD) use throughout 1 year following MOUD initiation and to examine the association of trajectory membership with HIV testing among people who inject drugs in India.
Allison M. McFall, Lakshmi Ganapathi, Mihili P. Gunaratne, Aylur K. Srikrishnan, Conjeevaram K. Vasudevan, Santhanam Anand, Sunil S. Solomon, Shruti H. Mehta, Gregory M. Lucas   +8 more
wiley   +1 more source

Autoantibodies neutralizing type 1 interferons in two cohorts of people with HIV. [PDF]

J Hum Immun
Jensen JA, Mørk N, Tolstrup M, Søgaard O, Dalhuisen T, Rodriguez A, Hoh R, Peluso MJ, Deeks SG, Casanova JL, Mogensen TH.   +10 more
europepmc   +1 more source

Daily or near‐daily cannabis and alcohol use by adults in the United States: A comparison across age groups

Addiction, Volume 120, Issue 4, Page 779-782, April 2025.
Abstract Background and aims Patterns of daily or near‐daily (DND) use of alcohol and cannabis among adults in the United States have been changing. The current study measured how these shifts have occurred across developmental periods of adulthood. Design, Setting, and Participants U.S.
Megan E. Patrick
wiley   +1 more source

The Changing Spectrum of Cognitive Impairment in People with HIV; Establishment and Updates of the International HIV-Cognition Working Group. [PDF]

Curr HIV/AIDS Rep
Nightingale S.
europepmc   +1 more source

Associations of cannabis use, tobacco use and co‐use with brain volume: A systematic review and meta‐analysis

Addiction, EarlyView.
Abstract Background and aims Cannabis is the most widely used illicit drug worldwide and is often co‐used with tobacco, the leading cause of preventable death. Although cannabis and tobacco have distinct neurobiological actions, their associations with brain volumes are unclear.
Katherine Sawyer, Tom P. Freeman, Martine Skumlien, Esther Walton, Thomas Lancaster, Jorien L. Treur, Valentina Lorenzetti, Anna K. M. Blackwell, Chloe Burke, Richie J. Carr, Constantinos Constantinides, Maisie Cox, Sarah Dance, Shadi Daryan, Sorcha Hamilton, Tom Jenkins, Gemma M. J. Taylor   +16 more
wiley   +1 more source

Elevated neurotransmitter levels in people with HIV are associated with attention function. [PDF]

Neurobiol Dis
Salsano I, John JA, Glesinger RJ, Garrison GM, Kress KA, Petts AJ, Rice DL, Ende GC, Horne LK, Coutant AT, May-Weeks PE, Oeltzschner G, Wilson TW.   +12 more
europepmc   +1 more source